经皮穴位电刺激对接受慢性阿片治疗的癌症患者健康相关生活质量的影响:一项随机临床试验的二次分析OA
Effects of transcutaneous electrical acupoint stimulation on health-related quality of life in cancer patients receiving chronic opioid therapy:A secondary analysis from a randomized clinical trial
背景:癌症相关性疼痛(CRP)是晚期恶性肿瘤患者常见的并发症,显著影响患者的健康相关生活质量(HRQOL).目前缺乏多中心、大规模的随机临床试验来研究经皮穴位电刺激(TEAS)在改善CRP患者生活质量方面的作用.目的:该研究拟评估TEAS对癌症疼痛患者HRQOL的影响,探讨癌症疼痛与生活质量之间的关联,并研究TEAS具体通过哪些方面提升生活质量.方法:基于一项纳入160例接受慢性阿片药物镇痛的CRP患者的随机对照试验结果(编号:ChiCTR-TRC-13003803,伦理已获批),对HRQOL相关指标进行二次分析.该母研究于2014年至2018年间开展,比较了为期3周的TEAS干预(刺激夹脊穴及四肢镇痛穴组)与假TEAS的疗效.二次分析的主要结局指标为第3周KPS评分的变化量.次要结局指标包括第3、4和5周的KPS评分及EQ-5D-3L评分,及TEAS干预后的BPI-Ⅰ评分等.结果:与假TEAS组相比,真TEAS组在第3周KPS评分变化量上显示出更显著的差异,但未达到最小临床重要差异阈值.第3周KPS评分变化量与癌症类型、性别、年龄、身高或体重无显著相关性(P>0.05).第3周时,NRS疼痛评分越低,KPS评分的平均改善幅度越大,二者呈负相关(r=-0.17,P<0.05),在行走、工作、情绪和睡眠方面尤为明显(BPI-Ⅰ均P<0.05).第5周时,接受真TEAS治疗的患者在活动能力、疼痛/不适以及焦虑/抑郁方面的改善更为显著(EQ-5D-3L均P<0.05).结论:二次分析表明,TEAS疗法可能给CRP患者带来统计学差异显著的HRQOL改善,该改善在第3、4和5周均可观察到;这些改善可能与TEAS镇痛所致的身体机能和情绪状态提升有关,但变化程度并未达到最小临床重要差异阈值.
Background:Cancer-related pain(CRP),a common complication among patients with advanced malignant tu-mors,significantly impacts the health-related quality of life(HRQOL)for these patients.There is still a lack of multi-center large-scale randomized clinical trials investigating the efficacy of acupuncture therapy,particularly transcutaneous electrical acupoint stimulation(TEAS),in enhancing the health-related quality of life(HRQOL)among patients suffering from cancer-related pain. Objective:To assess the effects of TEAS on HRQOL in cancer pain patients.Aimed to examine the correlation between cancer pain and HRQOL,and investigate the particular aspects in which TEAS enhances HRQOL. Methods:A secondary analysis of HRQOL outcomes was conducted based on results from a randomized controlled trial involving 160 CRP patients undergoing chronic opioid therapy(No.ChiCTR-TRC-13003803,2013/08/27,URL:https://www.chictr.org.cn/showproj.html?proj=5759,with ethical protocol approved).The parent trial was carried out between 2014 and 2018 and compared the efficacy of a 3-week TEAS intervention applied to Jiaji(EX-B2)and limb analgesic acupoints versus sham-TEAS.In this secondary analysis,the primary outcome was the mean change in karnofsky performance status(KPS)value from baseline to Week 3.Secondary outcomes included the KPS value and EQ-5D-3 L scores at week 3,4 and 5,and BPI-Ⅰ scores after TEAS intervention. Results:True-TEAS suggested greater differences in the mean change of KPS value than sham-TEAS(P<0.05 at each timepoint),though the magnitude of change did not meet the minimum clinically important difference(MCID)threshold.The 3-week change were not significantly correlated with cancer type,sex,age,height or weight(-0.19,P>0.05).At week 3,reduced pain scores were associated with greater mean changes in KPS(Spearman's r=-0.17,P<0.05),especially in walking,working,mood,and sleep(all P<0.05 in BPI-Ⅰ).At week 5,true-TEAS patients reported fewer mobility,pain/discomfort,and anxiety/depression(all P<0.05 in EQ-5D-3 L). Conclusion:This secondary analysis indicates that TEAS therapy may yield statistically significant improvements in HRQOL in CRP patients,observed at weeks 3,4,and 5.These improvements may be related to enhanced physical capability and mood status driven by greater analgesic effects,though the magnitude of change did not meet the MCID threshold.
吕政仪;季聪华;梁宜;鲍关爱;吴雨欣;龚黎燕;张卫平;黄睿;周杰;楼海舟;Jianyi Liang
附属邵逸夫医院,浙江大学医学院,浙江大学,杭州 310002,浙江,中国临床评价中心,浙江中医药大学第一附属医院,杭州 310002,浙江,中国针灸科,浙江中医药大学第三附属医院,杭州 310013,浙江,中国中西医结合科,浙江省肿瘤医院,杭州 310011,浙江,中国第三临床医学院,浙江中医药大学,杭州 310051,浙江,中国中西医结合科,浙江省肿瘤医院,杭州 310011,浙江,中国肿瘤科,浙江中医药大学第三附属医院,杭州 310013,浙江,中国针灸推拿科,温州中心医院,温州 325000,浙江,中国针灸科,浙江中医药大学第三附属医院,杭州 310013,浙江,中国附属邵逸夫医院,浙江大学医学院,浙江大学,杭州 310002,浙江,中国Karlsruhe Institute of Technology,Department of Mechanical Engineering,Karlsruhe 76131,Baden-Württemberg,Germany
经皮穴位电刺激针灸癌性疼痛健康相关生活质量慢性阿片药物治疗
Transcutaneous electrical acupoint stimulationAcupunctureCancer-related painHealth-related quality of lifeChronic opioid therapy
《临床传统医学和药理学(英文)》 2026 (2)
23-32,10
This work was supported by the Key Project of Health Science and Technology Program of National Health Commission and Zhejiang Province(No.WKJ-ZI-2436),the Key Foundation of Chinese Medicine Research Program of Zhejiang Province(No.2021ZZ017),the Gen-eral Medical Science and Technology Project of Zhejiang Province(No.2014KYA162),the General Scientific Research Project from the Educa-tion Department of Zhejiang Province(No.Y202248799),and the Zhe-jiang Provincial Administration of Traditional Chinese Medicine(No.2011ZB080).
评论